Before any clinical site is activated for patient enrollment, it must demonstrate full operational readiness during the Site Initiation Visit (SIV). A well-designed site readiness checklist serves as a critical quality assurance tool that enables Clinical Research Associates (CRAs), sponsors, and site staff to verify that all regulatory, logistical, and procedural components are in place. This tutorial provides a step-by-step approach to building and using site readiness checklists effectively to streamline trial startup and support audit preparedness.

Why a Site Readiness Checklist Is Essential

Without a structured checklist, critical steps may be missed, such as:

• Regulatory approvals not in place
• Untrained site staff handling study procedures
• Investigational product (IP) storage non-compliant with specifications
• Missing essential documents in the Investigator Site File (ISF)

A checklist standardizes site evaluation and ensures consistent practices across all clinical trial sites in compliance with USFDA and EMA guidelines.

Key Components of a Site Readiness Checklist

The checklist should be divided into the following categories, each encompassing critical startup elements:

1. Regulatory Documentation

• IRB/EC approval letter for protocol and ICF
• Signed and dated 1572 or country-specific equivalent
• GCP certificates for all site personnel
• Curricula vitae (CVs) of the PI and Sub-Is
• Delegation of Authority Log

2. Site Staff Training

• Protocol-specific training completed and documented
• System training (EDC, IWRS, ePRO) completed
• IP accountability and storage training provided

3. Investigational Product Management

• Temperature-controlled storage verified with backup monitoring
• Drug Accountability Logs available and prepared
• Unblinding procedures understood by PI
• Receipt of IP shipment documented

4. Equipment and Facility Readiness

• Calibrated equipment (centrifuges, ECG machines, etc.)
• Lab kits and sample processing supplies received
• Secure and locked storage for documents and IP
• Environmental controls in place and monitored

5. Site Personnel and Communication

• Staff roles and responsibilities clearly documented
• Contact list shared with sponsor and updated
• CRA and site staff communication plan agreed
• Escalation procedures defined

6. Source Documentation and ISF Review

• Source templates approved and filed
• Investigator Site File (ISF) organized with version control
• Pre-screening logs available (if applicable)
• Checklists signed by CRA and PI

Ensure that all components follow the relevant GMP documentation and Good Clinical Practice (GCP) principles.

Sample Site Readiness Checklist Template

1. ☐ IRB Approval Letter (Protocol and ICF)
2. ☐ Form 1572 Signed by PI
3. ☐ CV and GCP Certificate of PI and Sub-Is
4. ☐ Delegation of Authority Log Complete
5. ☐ Protocol and IP Training Completed
6. ☐ EDC/IWRS Training Complete
7. ☐ Drug Storage Conditions Verified
8. ☐ IP Accountability Records Available
9. ☐ All Site Equipment Calibrated and Documented
10. ☐ ISF Assembled and Reviewed
11. ☐ Site Contact List Confirmed
12. ☐ CRA/Monitor Communication Plan Finalized

Store this template in editable format at both the CRA and site end, and file a scanned signed version in the Trial Master File (TMF).

When to Use the Checklist

• Before and during the SIV to assess readiness
• After SIV as part of the activation approval process
• Before subject screening begins
• Prior to audits or inspections for readiness validation

Best Practices

1. Customize the checklist for study phase and therapeutic area
2. Review each checklist item with the site in real time
3. Use digital platforms for version control and signoff
4. Include a section for CRA observations and site action items
5. Cross-reference with Stability Studies templates for validation readiness

CRA Responsibilities

• Ensure checklist completion before site activation
• Flag missing items in the SIV Follow-Up Letter
• Verify all documents filed in ISF and TMF
• Obtain PI and CRA signatures on final checklist

Conclusion

A site readiness checklist is a cornerstone of clinical trial startup success. It enables CRAs and sponsors to ensure that nothing is overlooked and that each site meets all operational, regulatory, and protocol-specific requirements. By leveraging structured checklists, sponsors can reduce the risk of protocol deviations, site delays, and regulatory findings—ultimately ensuring a faster and safer path to study completion.